Name: 글로벌 시장 동향
SKU: MD1672
Availability: InStock

보고서 요약(국문)

개요
글로벌 정형외과 생체재료 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
생체재료는 치료 또는 진단 검사와 같은 의학적 목적을 위해 생물학적 시스템과 상호 작용하도록 설계된 물질입니다. 생체재료는 금속 또는 고분자 성분, 세라믹 또는 복합 재료를 사용하여 다양한 화학적 기술로 실험실에서 만들 수 있으며, 자연에서 얻을 수도 있습니다.
정형외과 생체재료는 뼈를 고정하는 임시 임플란트부터 영구 임플란트 재료 및 생분해성 임플란트에 이르기까지 다양하게 사용됩니다. 일반적인 정형외과 생체재료에는 인산칼슘 시멘트, 생체활성 유리, 고분자, 금속 및 복합재료가 있습니다.
시장 동향
정형외과 수술 건수 증가
정형외과 수술 건수 증가는 시장 성장의 중요한 동인입니다. 정형외과 수술에서 생체 재료는 손상되거나 질병에 걸린 조직을 대체하거나 재생하여 생리적 기능을 향상시키는 데 사용될 수 있습니다.
예를 들어, 미국 인공관절 치환 등록소(AJRR)는 2022년 연례 보고서를 통해 2012년 이후 1,250개 이상의 병원, 외래 수술 센터 및 개인 진료 그룹에서 280만 건 이상의 고관절 및 무릎 수술이 시행되었으며, 이는 전년 대비 누적 시술 건수가 14% 증가한 수치임을 보여줍니다. 따라서 정형외과 수술에 사용될 수 있는 생체 재료에 대한 수요가 증가하고 있습니다.
또한, 세계보건기구(WHO)에 따르면 매년 약 2천만~5천만 명이 교통사고로 비치명적인 부상을 입습니다. 마찬가지로, 미국 질병통제예방센터(CDC)에 따르면 2020년에는 약 2,885,545건의 비치명적인 부상으로 수술이 필요한 외래 환자가 보고되었습니다. 이처럼 부상 증가로 인해 정형외과용 생체 재료의 사용이 증가하여 시장 성장을 촉진하고 있습니다.

또한, 류마티스 관절염 및 골관절염과 같은 만성 질환 환자 수 증가와 신제품 출시와 같은 주요 성장 동력이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
엄격한 규제 승인
시판 전 승인 및 장기간의 임상 시험은 정형외과 생체 재료 시장에 적용되는 엄격한 규제 기준 중 하나입니다. 이러한 비용이 많이 들고 시간이 오래 걸리는 규제 절차는 개발 비용을 증가시키고 새로운 생체 재료 제품의 시장 출시를 지연시킵니다. 이러한 요인들은 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
글로벌 정형외과 생체 재료 시장은 재료 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
인산칼슘 시멘트는 시장 점유율의 약 47.8%를 차지했습니다.
인산칼슘 시멘트는 분말 및 액체 형태의 생체 활성 및 생분해성 접합 재료입니다. 새로운 정형외과 생체 재료 출시 증가와 기술 발전으로 인해 인산칼슘 시멘트는 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

예를 들어, 2022년 7월, Curasan AG는 악안면, 정형외과 및 외상 수술용 골 결손 충전제인 CERASORB CPC(인산칼슘 시멘트)를 출시했습니다. CERASORB CPC는 생체 적합성 오일에 미세하게 분산된 칼슘 및 인산염으로 구성된 합성, 생체 적합성, 골 전도성 및 생체 흡수성 무기질 골 시멘트입니다.
또한, 2022년 5월 Granulab (M) Sdn Bhd는 말레이시아 최초의 할랄 인증 합성 골 시멘트인 Prosteomax를 출시했습니다. 이는 말레이시아 이슬람 개발부(IDD)로부터 할랄 인증을 받은 혁신적인 인산칼슘 기반 합성 골 시멘트입니다.
지역 분석
북미는 전 세계 정형외과 생체 재료 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
전 세계 정형외과 생체 재료 시장은 북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카로 구분됩니다.

북미는 정형외과 수술 증가와 신제품 출시 등의 요인으로 인해 상당한 시장 점유율을 유지해 왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 2023년 4월 Abyrx, Inc.는 골 결손 충전재 및 두개골 골 시멘트로 사용 가능한 MONTAGE 경화형 흡수성 골 퍼티에 대해 미국 FDA 승인을 받았습니다. MONTAGE는 손으로 성형할 수 있는 경화형 퍼티로, 혼합 후 몇 분 안에 뼈와 유사한 특성을 나타내며 수술 중 적용에 있어 독특한 장점을 제공합니다.
또한, 2022년 2월 Orthofix Medical Inc.는 경추 및 요추 융합술에 사용되는 합성 생체 활성 골 이식재인 Opus BA를 출시했습니다. Opus BA는 뼈 구조의 안정성에 필수적이지 않은 골격계의 간극이나 구멍을 채우는 데 사용할 수 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 정형외과 생체 재료 시장에 상당한 영향을 미쳤습니다. 2020년 초 팬데믹 발생으로 인해 광범위한 봉쇄와 제한 조치가 시행되면서 전 세계적으로 정기적인 진단, 치료, 생체 재료 출시 및 상담에 차질이 생겼습니다. 팬데믹 발생으로 많은 제약 및 의료기기 제조업체는 인력 부족에 직면했고, 봉쇄 조치로 인해 직원들이 출퇴근하지 못했습니다. 따라서 이러한 요인들로 인해 정형외과 생체 재료 시장은 예측 기간 동안 다소 영향을 받을 것으로 예상됩니다.
경쟁 환경
주요 글로벌 시장 참여업체로는 Stryker Corporation, Koninklijke DSM N.V., Evonik Industries AG, Globus Medical, Zimmer Biomet Holdings Inc., Medbone, Invibio Ltd., CAM Bioceramics B.V., Exactech Inc., DePuy Synthes 등이 있습니다.
주요 개발 사항
• 2023년 6월, Invibio Biomaterial Solutions는 Paragon Medical과 협력하여 PEEK-OPTIMA 초강화 의료용 외상 기기를 제조하기 시작했습니다.

• 2022년 8월, Oxford Performance Materials는 SINTX Technologies와 협력하여 새로운 종류의 정형외과용 코팅을 성공적으로 개발했습니다. 이 코팅은 금속 임플란트의 임상적 한계를 극복하는 것을 목표로 합니다.

• 2020년 9월, Evonik은 뼈와 임플란트 사이의 유합을 향상시키는 독특한 골전도성 폴리에테르 에테르 케톤(PEEK)을 의료 기술 시장에 선보였습니다.

보고서 구매 이유:

• 재료 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 정형외과 생체재료 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 발굴하기 위해

• 모든 세그먼트를 포함한 정형외과 생체재료 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서

• 주요 기업의 핵심 제품 목록이 담긴 Excel 파일 제공 글로벌 정형외과 생체재료 시장 보고서는 약 61개의 표, 63개의 그림, 그리고 185페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Orthopedic Biomaterials Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose, either a therapeutic or a diagnostic test. Biomaterials can be created in the lab using a number of chemical techniques using metallic or polymeric components, ceramics, or composite materials, and biomaterials can also be obtained from nature.
Orthopedic biomaterials are used from temporary implants to fix bone to permanent implant materials and bioabsorbable implants. Common orthopedic biomaterials include calcium phosphate cements, bioactive glasses, polymers, metals, and composites.
Market Dynamics
The increasing number of orthopedic surgeries
The increasing number of orthopedic surgeries acts as a significant driver for market growth. In orthopedic surgeries, biomaterials can be utilized to replace or regenerate damaged or diseased tissues in order to improve their physiological performance.
For instance, the American Joint Replacement Registry (AJRR), published its 2022 annual report that demonstrates an overall cumulative procedural growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, ambulatory surgery centers, and private practice groups. Hence, the demand for biomaterials increases that can be used in orthopedic surgeries.
Also, according to the WHO, approximately 20-50 million people get non-fatal injuries because of road casualties yearly. Likewise, according to the CDC, roughly 2,885,545 ambulatory cases were reported with non-fatal injuries requiring surgery in 2020. Thus, due to these injuries, the use of orthopedic biomaterials increased which help to boost the market.
Furthermore, significant growth drivers such as the growing number of cases of chronic diseases like rheumatoid arthritis, and osteoarthritis, and, product launches are expected to drive the market in the forecast period.
Stringent regulatory approvals
Pre-market approval and lengthy clinical trials are among the strict regulatory criteria that apply to the orthopedic biomaterial market. These expensive and time-consuming regulatory procedures raise the overall cost of development while delaying the release of novel biomaterial products into the market. The above factors are expected to hamper the market growth.
Segment Analysis
The global orthopedic biomaterials market is segmented based on material type, application, end users and region.
Calcium phosphate cement accounted for approximately 47.8% of the market share
Calcium phosphate cement is a bioactive and biodegradable grafting material in the form of powder and liquid. Calcium phosphate cements are expected to hold the largest market share over the period forecast owing to increasing new orthopedic biomaterial launches and technical advancements.
For instance, in July 2022, Curasan AG launched the CERASORB CPC (Calcium Phosphate Cement) Bone Void Fillers for maxillofacial, orthopedic, and trauma surgery. CERASORB CPC is a synthetic, biocompatible, osteoconductive, and bioresorbable mineral bone cement composed of calcium and phosphate salts finely dispersed in a biocompatible oil.
Additionally, in May 2022, Granulab (M) Sdn Bhd launched Malaysia's first halal-certified synthetic bone cement called Prosteomax. It is an innovative calcium phosphate-based synthetic bone cement that has been certified halal by the Islamic Development Department Malaysia.
Geographical Analysis
North America is expected to hold a significant position in the global orthopedic biomaterials market share
The global orthopedic biomaterials market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of orthopedic surgeries, and product launches, this trend is anticipated to continue throughout the forecast period.
For instance, in April 2023, Abyrx, Inc. received U.S. FDA clearances for the MONTAGE Settable, Resorbable Bone Putty as both a bone void filler and cranial bone cement. MONTAGE is a hand-moldable, hardening putty that, within minutes after mixing, develops bone-like characteristics and offers a unique intraoperative application.
Additionally, in February 2022, Orthofix Medical Inc. launched the Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures. Opus BA can be used to fill skeletal system gaps or holes that are not essential to the stability of the bony structure.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global orthopedic biomaterials market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, biomaterial launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the orthopedic biomaterials market is expected to be moderately affected over the forecast period.
Competitive Landscape
The major global players in the market include Stryker Corporation, Koninklijke DSM N.V., Evonik Industries AG, Globus Medical, Zimmer Biomet Holdings Inc., Medbone, Invibio Ltd., CAM Bioceramics B.V., Exactech Inc., DePuy Synthes among others.
Key Developments
• In June 2023, Invibio Biomaterial Solutions collaborated with Paragon Medical to manufacture composite PEEK-OPTIMA Ultra-Reinforced medical trauma devices.
• In August 2022, Oxford Performance Materials in collaboration with SINTX Technologies successfully developed a new class of orthopedic coatings. These coatings are targeted at overcoming the clinical limitations of metallic implants.
• In September 2020, Evonik introduced a unique osteoconductive polyether ether ketone (PEEK) for the medical technology market that improves the fusion between bone and an implant.
Why Purchase the Report?
• To visualize the global orthopedic biomaterials market segmentation based on material type, application, end users and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of orthopedic biomaterials market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global orthopedic biomaterials market report would provide approximately 61 tables, 63 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Material Type
3.2. Snippet by Application
3.3. Snippet by End Users
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing number of orthopedic surgeries
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. Stringent regulatory approvals
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Material Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
7.1.2. Market Attractiveness Index, By Material Type
7.2. Calcium Phosphate Cements*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ceramics & Bioactive Glasses
7.4. Polymers
7.5. Metal
7.6. Composites
7.7. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Orthopedic Implants*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Joint Replacement
8.4. Orthobiologics
8.5. Viscosupplementation
8.6. Bio-resorbable Tissue Fixation
8.7. Others
9. By End Users
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
9.1.2. Market Attractiveness Index, By End Users
9.2. Hospital And Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Orthopedic Clinics
9.4. Ambulatory Surgical Centers
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Stryker Corporation
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. DSM Biomedical
12.3. Evonik Industries AG
12.4. Globus Medical
12.5. Zimmer Biomet Holdings Inc.
12.6. Medbone
12.7. Invibio Ltd.
12.8. CAM Bioceramics B.V.
12.9. Exactech Inc.
12.10. DePuy Synthes
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Stryker Corporation, 4. Key Developments, DSM Biomedical, Evonik Industries AG, Globus Medical, Zimmer Biomet Holdings Inc., Medbone, Invibio Ltd., CAM Bioceramics B.V., Exactech Inc., DePuy Synthes

표 목록 (Tables)

List of Tables Table 1 Global Orthopedic Biomaterials Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Orthopedic Biomaterials Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Orthopedic Biomaterials Market Value, By End Users, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Orthopedic Biomaterials Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Orthopedic Biomaterials Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 7 Global Orthopedic Biomaterials Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 9 Global Orthopedic Biomaterials Market Value, By End Users, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 11 Global Orthopedic Biomaterials Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Orthopedic Biomaterials Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 14 North America Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 15 North America Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 16 North America Orthopedic Biomaterials Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 18 South America Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 19 South America Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 20 South America Orthopedic Biomaterials Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 22 Europe Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 23 Europe Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 24 Europe Orthopedic Biomaterials Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Orthopedic Biomaterials Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Orthopedic Biomaterials Market Value, By Material Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Orthopedic Biomaterials Market Value, By Application, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Orthopedic Biomaterials Market Value, By End Users, 2021-2030 (US$ Million)

Table 32 Stryker Corporation: Overview

Table 33 Stryker Corporation: Product Portfolio

Table 34 Stryker Corporation: Key Developments

Table 35 Koninklijke DSM N.V.: Overview

Table 36 Koninklijke DSM N.V.: Product Portfolio

Table 37 Koninklijke DSM N.V.: Key Developments

Table 38 Evonik Industries AG: Overview

Table 39 Evonik Industries AG: Product Portfolio

Table 40 Evonik Industries AG: Key Developments

Table 41 Globus Medical: Overview

Table 42 Globus Medical: Product Portfolio

Table 43 Globus Medical: Key Developments

Table 44 Zimmer Biomet Holdings Inc.: Overview

Table 45 Zimmer Biomet Holdings Inc.: Product Portfolio

Table 46 Zimmer Biomet Holdings Inc.: Key Developments

Table 47 Medbone: Overview

Table 48 Medbone: Product Portfolio

Table 49 Medbone: Key Developments

Table 50 Invibio Ltd.: Overview

Table 51 Invibio Ltd.: Product Portfolio

Table 52 Invibio Ltd.: Key Developments

Table 53 CAM Bioceramics B.V.: Overview

Table 54 CAM Bioceramics B.V.: Product Portfolio

Table 55 CAM Bioceramics B.V.: Key Developments

Table 56 Exactech Inc.: Overview

Table 57 Exactech Inc.: Product Portfolio

Table 58 Exactech Inc.: Key Developments

Table 59 DePuy Synthes: Overview

Table 60 DePuy Synthes: Product Portfolio

Table 61 DePuy Synthes: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 2 Global Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 3 Global Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 5 Global Orthopedic Biomaterials Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Orthopedic Biomaterials Market Y-o-Y Growth, By Material Type, 2022-2030 (%)

Figure 7 Ceramics and Bioactive Glasses Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 8 Polymers Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 9 Calcium Phosphate Cements Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 10 Metal Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 11 Composites Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 12 Others Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 13 Global Orthopedic Biomaterials Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 14 Orthopedic Implants Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 15 Joint Replacement Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 16 Orthobiologics Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 17 Viscosupplementation Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 18 Bio-resorbable Tissue Fixation Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 19 Others Application in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 20 Global Orthopedic Biomaterials Market Y-o-Y Growth, By End Users, 2022-2030 (%)

Figure 21 Hospital And Clinics End Users in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 22 Orthopedic Clinics End Users in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 23 Ambulatory Surgical Centers End Users in Global Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 24 Global Orthopedic Biomaterials Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 25 North America Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 26 Asia-Pacific Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 27 Europe Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 28 South America Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 29 Middle East and Africa Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 30 North America Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 31 North America Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 32 North America Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 33 North America Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 34 North America Orthopedic Biomaterials Market Share, By Country, 2022 & 2030 (%)

Figure 35 South America Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 36 South America Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 37 South America Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 38 South America Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 39 South America Orthopedic Biomaterials Market Share, By Country, 2022 & 2030 (%)

Figure 40 Europe Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 41 Europe Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 42 Europe Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 43 Europe Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 44 Europe Orthopedic Biomaterials Market Share, By Country, 2022 & 2030 (%)

Figure 45 Asia-Pacific Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 46 Asia-Pacific Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 47 Asia-Pacific Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 48 Asia-Pacific Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 49 Asia-Pacific Orthopedic Biomaterials Market Share, By Country, 2022 & 2030 (%)

Figure 50 Middle East & Africa Orthopedic Biomaterials Market Value, 2021-2030 (US$ Million)

Figure 51 Middle East & Africa Orthopedic Biomaterials Market Share, By Material Type, 2022 & 2030 (%)

Figure 52 Middle East & Africa Orthopedic Biomaterials Market Share, By Application, 2022 & 2030 (%)

Figure 53 Middle East & Africa Orthopedic Biomaterials Market Share, By End Users, 2022 & 2030 (%)

Figure 54 Stryker Corporation: Financials

Figure 55 Koninklijke DSM N.V.: Financials

Figure 56 Evonik Industries AG: Financials

Figure 57 Globus Medical: Financials

Figure 58 Zimmer Biomet Holdings Inc.: Financials

Figure 59 Medbone: Financials

Figure 60 Invibio Ltd.: Financials

Figure 61 CAM Bioceramics B.V.: Financials

Figure 62 Exactech Inc.: Financials

Figure 63 DePuy Synthes: Financials

글로벌 정형외과 생체재료 시장 – 2023-2030

Global Orthopedic Biomaterials Market - 2023-2030